Lumavita is uniquely positioned as the only specialty pharmaceutical company dedicated to the global development and marketing of new drugs to combat infections for women's health.

Latest News

03.09.2010
Lumavita AG closes a Series B financing round of CHF 11 M
Read More

© 2008 Copyright Lumavita AG All rights reserved.